載入...
Free‐water and BOLD imaging changes in Parkinson's disease patients chronically treated with a MAO‐B inhibitor
Rasagiline is a monoamine oxidase type B inhibitor that possesses no amphetamine‐like properties, and provides symptomatic relief in early and late stages of Parkinson's disease (PD). Data in animal models of PD suggest that chronic administration of rasagiline is associated with structural cha...
Na minha lista:
發表在: | Hum Brain Mapp |
---|---|
Main Authors: | , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
John Wiley and Sons Inc.
2016
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4945383/ https://ncbi.nlm.nih.gov/pubmed/27089850 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hbm.23213 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|